Evaluation of xanthotoxol for central nervous system activity

Area of Science:

• Pharmacology
• Neuroscience
• Toxicology

Background:

• Xanthotoxol (XT), or 8-hydroxypsoralen, is a compound with potential central nervous system activity.
• Understanding its pharmacological profile is crucial for evaluating its therapeutic potential.

Purpose of the Study:

• To investigate the sedative and behavioral effects of Xanthotoxol (XT) in multiple animal species.
• To assess the acute and chronic toxicity of XT, including reproductive and teratogenic effects.

Main Methods:

• Dose-response studies were conducted in dogs, cats, rats, mice, and hamsters to evaluate sedative activity, locomotor behavior, and responses to amphetamine and foot-shock stimuli.
• Pentobarbital-induced narcosis potentiation and conditioned avoidance responses were also assessed.
• Acute toxicity (LD50) and 6-month chronic toxicity studies in rats, including reproductive and teratogenic assessments, were performed.

Main Results:

• XT exhibited dose-graded sedative activity and reduced locomotor activity in tested species, with varying potency compared to diazepam.
• XT antagonized amphetamine-induced hypermobility, elevated seizure thresholds, and potentiated pentobarbital-induced narcosis.
• Acute LD50 in mice was 468 mg/kg. Chronic administration in rats for 6 months revealed no adverse effects on reproduction or endocrine function, and no teratogenic effects were observed in the F1 generation.

Conclusions:

• Xanthotoxol (XT) possesses significant sedative and behavioral modifying properties across multiple species.
• XT demonstrates a favorable safety profile with no observed reproductive or teratogenic toxicity in rodent models.